In order for coverage to be available under this part for covered part D drugs (as defined in section
1395w–102(e) of this title) of a manufacturer, the manufacturer must—
(1)participate in the Medicare coverage gap discount program under section
1395w–114a of this title;
(2)have entered into and have in effect an agreement described in subsection (b) of such section with the Secretary; and
(3)have entered into and have in effect, under terms and conditions specified by the Secretary, a contract with a third party that the Secretary has entered into a contract with under subsection (d)(3) of such section.
(b) Effective date
Subsection (a) shall apply to covered part D drugs dispensed under this part on or after January 1, 2011.
(c) Authorizing coverage for drugs not covered under agreements
Subsection (a) shall not apply to the dispensing of a covered part D drug if—
(1)the Secretary has made a determination that the availability of the drug is essential to the health of beneficiaries under this part; or
(2)the Secretary determines that in the period beginning on January 1, 2011, and [1] December 31, 2011, there were extenuating circumstances.
(d) Definition of manufacturer
In this section, the term “manufacturer” has the meaning given such term in section
1395w–114a(g)(5) of this title.
[1] So in original. Probably should be followed by “ending on”.
In order for coverage to be available under this part for covered part D drugs (as defined in section
1395w–102(e) of this title) of a manufacturer, the manufacturer must—
(1)participate in the Medicare coverage gap discount program under section
1395w–114a of this title;
(2)have entered into and have in effect an agreement described in subsection (b) of such section with the Secretary; and
(3)have entered into and have in effect, under terms and conditions specified by the Secretary, a contract with a third party that the Secretary has entered into a contract with under subsection (d)(3) of such section.
(b) Effective date
Subsection (a) shall apply to covered part D drugs dispensed under this part on or after January 1, 2011.
(c) Authorizing coverage for drugs not covered under agreements
Subsection (a) shall not apply to the dispensing of a covered part D drug if—
(1)the Secretary has made a determination that the availability of the drug is essential to the health of beneficiaries under this part; or
(2)the Secretary determines that in the period beginning on January 1, 2011, and [1] December 31, 2011, there were extenuating circumstances.
(d) Definition of manufacturer
In this section, the term “manufacturer” has the meaning given such term in section
1395w–114a(g)(5) of this title.
[1] So in original. Probably should be followed by “ending on”.
2010—Subsec. (b). Pub. L. 111–152, § 1101(b)(1)(A), substituted “January 1, 2011” for “July 1, 2010”.
Subsec. (c)(2). Pub. L. 111–152, § 1101(b)(1)(B), substituted “January 1, 2011, and December 31, 2011,” for “July 1, 2010, and ending on December 31, 2010,”.
The table below lists the classification updates, since Jan. 3, 2012, for this section. Updates to a broader range of sections may be found at the update page for containing chapter, title, etc.
The most recent Classification Table update that we have noticed was Monday, June 17, 2013
An empty table indicates that we see no relevant changes listed in the classification tables. If you suspect that our system may be missing something, please double-check with the Office of the Law Revision Counsel.
42 USC
Description of Change
Session Year
Public Law
Statutes at Large
This is a list of parts within the Code of Federal Regulations for which this US Code section provides rulemaking authority.
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.